CISPLATIN AND ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY IN PATIENTS WITH SMALL CELL LUNG-CANCER

被引：19

作者：

FIGOLI, F

VERONESI, A

ARDIZZONI, A

CANOBBIO, L

BRUSCHI, G

MAZZA, F

ZAGONEL, V

LORE, G

ROSSO, R

MONFARDINI, S

机构：

[1] CTR RIFERIMENTO ONCOL,DIV MED ONCOL,AVIANO,ITALY

[2] TUMOR INST,DIV MED ONCOL,GENOVA,ITALY

[3] GEN HOSP,DIV PNEUMOL,PORDENONE,ITALY

来源：

CANCER INVESTIGATION | 1988年 / 6卷 / 01期

关键词：

D O I：

10.3109/07357908809077023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 5

页数：5

共 22 条

[1]

ARNOLD AM, 1981, LANCET, V2, P912

[2]

ASBURY RF, 1983, CANCER TREAT REP, V67, P951

[3]

CAVALLI F, 1978, CANCER TREAT REP, V62, P473

[4]

COHEN MH, 1977, CANCER TREAT REP, V61, P489

[5]

DOMBERNOWSKY P, 1979, CANCER TREAT REP, V63, P543

[6] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

OSOBA, D ;

FELD, R ;

SHEPHERD, FA ;

BAZOS, MJ ;

DEBOER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :65-71

[7]

EVANS WK, 1984, CANCER, V53, P1461, DOI 10.1002/1097-0142(19840401)53:7<1461::AID-CNCR2820530706>3.0.CO

[8]

2-N

[9]

ISSELL BF, 1985, CANCER TREAT REP, V69, P127

[10]

LEVENSON RM, 1985, CANCER TREAT REP, V65, P905

← 1 2 3 →